SkinHealth Systems Inc. is a global medical aesthetics company that provides an integrated ecosystem of clinically proven solutions for skin health. The company's flagship brand, Hydrafacial, offers hydradermabrasion treatments using the Syndeo, Elite Tower, and Allegro devices, along with proprietary consumables such as tips, solutions, and serums. Its portfolio includes SkinStylus, a microneedling and nano-channeling device acquired via Edge Systems Intermediate, LLC, and HydraScalp powered by Keravive, which targets scalp health and hair appearance. The company serves a worldwide network of providers and consumers, offering personalized treatments through its MyBeautyHealth mobile application and co-developed booster serums with various skincare brands. SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver treatment experiences across an omnichannel provider network.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage skinhealthsystems.com
Sector Healthcare IR page skinhealthsystems.com/ir-resources/investor-faqs
Tags
medical aesthetics, hydradermabrasion, microneedling, nano-channeling, scalp treatment, dermatology, cosmetic devices, proprietary consumables, booster serums, provider network, Hydrafacial, Syndeo, Elite Tower, Allegro, SkinStylus, SteriLock Microsystem, HydraScalp, Keravive, Keravive Peptide Solution, MyBeautyHealth, Edge Systems Intermediate LLC, Esthetic Medical Inc., HydraClear, Vortex Fusion Technology
Press page —

Metrics

Valuation  
Market cap $ 4.103M
Market cap (USD) $ 4.103M
P/E —
PEG —
P/BV 0.07
P/S 0.01
P/OCF 0.17
P/FCF 0.18
Dividend yield —
Turnover / mcap —
Returns  
ROE -16.9%
ROI -2.2%
ROIC -3.7%
Profit margin -3.2%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 596.8%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 8
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 300.79M 334.294M 397.991M 365.876M 260.086M 119.092M
Net profit -9.519M -29.098M -100.116M 44.384M -375.108M -29.175M
Free cash flow 37.182M 15.378M 17.925M -117.447M -39.562M -15.937M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 1.39 1.59 3.11 9.1 24.16 —
Price performance 12m -0.13 -0.49 -0.66 -0.62 — —

Filed figures

Figure Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 18.6M 46.8M 76.5M 54.7M 27.6M 21.7M
↳ YoY growth +152.1% +63.4% -28.5% -49.5% -21.4%
↳ 5y CAGR +3.2%
Lease liabilities (USD) — — 0.00 16.5M 17.6M 13.9M 16M 14.4M
Cash and deposits (USD) 3.58M 7.31M 3.27M 902M 568M 523M 370M 233M
Intangible assets (USD) — — 50.9M 56M 46.4M 62.1M 47.5M 35.8M
Right-of-use assets (USD) — — 0.00 15M 15.6M 12.1M 13.6M 11.6M
Cash flow detail
Operating cash flow (USD) — 1.73M -12.4M -28.4M -107M 21.8M 16.1M 37.5M
Purchases of property, plant and equipment (USD) — -8.77M -3.5M -11.2M -10.8M -3.83M -756,000 -303,000
Purchases of intangible assets (USD) — -1.65M -316,000 -4.42M -6.55M -9.22M -6.04M -4.86M
Change in receivables (cash effect) (USD) — -11M 3.7M -31M -32M 16.5M 20.8M 5.16M
Change in inventories (cash effect) (USD) — -4.77M -3.21M -9.44M -82.1M -22.6M -10.5M 15.8M
Change in payables (cash effect) (USD) — 4.31M 4.89M 10.5M 1.61M 15.8M -43.8M -7.18M
Share buybacks (cash effect) (USD) — 0.00 -154,000 0.00 -160M -30.2M 0.00 0.00
Interest paid (cash effect) (USD) — -15.7M -13.5M -10.2M -9.82M -9.38M -8.01M -14.4M
Income taxes paid (cash effect) (USD) — -861,000 -2.43M -1.7M 1.34M -2.27M -2.8M -3.95M
Share-based compensation (USD) — 103,000 363,000 12.4M 28.5M 22.5M 26.7M 14.8M
Operating cash flow before change in receivables (USD) — 12.8M -16.1M 2.65M -74.6M 5.23M -4.67M 32.3M
Free cash flow (OCF - PPE - intangibles) (USD) — -8.69M -16.3M -44M -124M 8.7M 9.34M 32.3M
Income detail
Research and development expense (USD) — 4.61M 3.41M 8.2M 8.44M 10.1M 6.3M 5.63M
↳ 5y CAGR +6.4% +10.5%
Total comprehensive income (USD) — -1.61M -29.1M -377M 41.1M -98.6M -33M -4M
Comprehensive income to owners (USD) — -1.61M -29.1M -377M 41.1M -98.6M -33M -4M
Provision for credit losses (USD) — 659,000 1.44M 854,000 1.62M 5.15M 5.13M 2.07M
Credit cost ratio (credit losses / average receivables) (%) — — — 2.6% 2.6% 7.9% 12.5% 8.4%
Reported Mar 1, 2022 Mar 1, 2022 Mar 1, 2022 Mar 1, 2022 Mar 1, 2023 Mar 12, 2024 Mar 12, 2025 Mar 12, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Long Beach, Calif., November 5, 2026 – SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial®, today announced financial results for the third quarter ended September 30, 2026 (“Q3 2026”).

“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction,” said Pedro Malha, President and Chief Executive Officer of SkinHealth Systems.

“We advanced each of our strategic priorities, strengthening commercial execution in the core Hydrafacial franchise, introducing clinically differentiated innovations designed to increase the value and productivity of our installed base, including our new HydraClearTM Treatment Booster, and expanding our portfolio with the launch of SkinStylusTM across six European markets. We also retired our 2026 debt as planned. We have a strong global brand, a substantial installed base and a more efficient operating model.

Oct 22, 2026

PDF Version

LONG BEACH, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report third quarter 2026 financial results after market close on Thursday, November 5, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.

A live webcast of the call can be accessed on the investor relations section of the Company’s website at skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion.

Disclosure Information SkinHealth Systems announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls and on the investor relations section of its website (skinhealthsystems.com) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About SkinHealth Systems SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.

Investors: [email protected] **Press:**[email protected]

Primary Logo

SkinHealth Systems Announces Reverse Stock Split Bull 0 Bear 4 Distress

Shares expected to begin trading on split-adjusted basis on October 14, 2026

LONG BEACH, Calif. – October 9, 2026 – SkinHealth Systems (Nasdaq: SKIN) (the “Company”), home to flagship brand Hydrafacial™, today announced that its Board of Directors has approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”). The Reverse Stock Split will become effective at 12:00 a.m. ET on October 14, 2026. The Company’s Class A Common Stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market (“Nasdaq”) at the market open on October 14, 2026, under the existing ticker symbol “SKIN” and a new CUSIP number of 88331L306.

At the Company’s Special Meeting of Stockholders held on September 22, 2026, stockholders approved a proposal authorizing a Reverse Stock Split with the exact ratio to be determined by the Board of Directors. The Reverse Stock Split is intended to help the Company regain compliance with Nasdaq’s $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

Prompts

SkinHealth Systems Inc. (ticker SKIN), listed in United States.

Company History

Date Change Detail
Apr 22, 2026 Renamed BEAUTY HEALTH CO → SkinHealth Systems Inc.
Jan 29, 2021 Renamed VESPER HEALTHCARE ACQUISITION CORP. → BEAUTY HEALTH CO